Fig. 4.
Endothelial growth factor receptor tyrosine kinase inhibitors.
(a) 4-anilinoquinazoline, (b) gefitinib, (c) erlotinib.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.